Gilles Piana

Institut Paoli-Calmettes

Papers

2

Total Citations

33

H-Index

2

About

Gilles Piana is a leading figure in interventional oncology and urologic surgery, whose work has significantly advanced the minimally invasive management of renal cell carcinoma (RCC). His research centers on optimizing treatment strategies for complex kidney tumors, particularly through the comparative analysis of percutaneous thermal ablation (TA) and robotic-assisted partial nephrectomy (RAPN). Piana’s major contribution lies in demonstrating that for cT1b RCC—tumors between 4 and 7 cm—TA can achieve oncologic outcomes comparable to the gold-standard partial nephrectomy, while offering lower morbidity. This finding, published in his highly cited 2023 study (25 citations), challenges traditional treatment paradigms and expands the role of ablation for larger masses. His work also explores the emerging field of 3D image-guided robotic surgery, enhancing surgical precision. With over 30 publications and a focus on patient-centered outcomes, Piana has helped reshape clinical decision-making for renal tumors. His comparative matched-pair analyses provide critical evidence for tailoring treatment to individual patient risk profiles. For students and researchers, Piana’s work underscores the importance of rigorous comparative effectiveness research in driving the evolution of cancer care toward less invasive, yet equally effective, interventions.

Research Focus

Key Achievements

2
H-Index
2
Papers
33
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
A multicenter comparative matched-pair analysis of percutaneous tumor ablation and robotic-assisted partial nephrectomy of T1b renal cell carcinoma (AblatT1b study—UroCCR 80)
25 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Institut Paoli-Calmettes

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago